اهمیت بیوانفورماتیک در فرایند طراحی دارو

مراجع و منابع این مقاله:

• Dibyajyoti, S., E.T. Bin, and P. Swati, Bioinformatics: The effects ...
• DiMasi, J.A., R.W. Hansen, and H.G. Grabowski, The price of ...
• Brown, D. and G. Superti-Furga, Rediscovering the sweet spot in ...
• Xia, X., Bioinformatics and Drug Discovery. Current topics in medicinal ...
• Iskar, M., et al., Drug discovery in the age of ...
• Whittaker, P.A., What is the relevance of bioinformatics to pharmacology? ...
• Ortega, S.S., L.C.L. Cara, and M.K. Salvador, In silico pharmacology ...
• Song, C.M., S.J. Lim, and J.C. Tong, Recent advances in ...
• Speck-Planche, A. and M. Cordeiro, Computer-aided drug design, synthesis and ...
• Macalino, S.J.Y., et al., Role of computer-aided drug design in ...
• Yamanishi, Y., et al., Drug-target interaction prediction from chemical, genomic ...
• Gilbert, J., P. Henske, and A. Singh, Rebuilding big pharma's ...
• Ratti, E. and D. Trist, Continuing evolution of the drug ...
• Adams, C.P. and V.V. Brantner, Spending on new drug development. ...
• Dickson, M. and J.P. Gagnon, Key factors in the rising ...
• Tsaioun, K., et al. ADDME–Avoiding Drug Development Mistakes Early: central ...
• Klein, D. and A. Tabarrok, The drug discovery, development and ...
• Tamimi, N.A. and P. Ellis, Drug development: from concept to ...
• Wierenga, D.E. and R.C. Eaton, Drug Development and Approval Process. ...
• Katara, P., Role of bioinformatics and pharmacogenomics in drug discovery ...
• Collier, R., Rapidly rising clinical trial costs worry researchers. ۲۰۰۹, ...
• Myers, S. and A. Baker, Drug discoveryan operating model for ...
• Simoens, S., Pricing and reimbursement of orphan drugs: the need ...
• Liang, B.A. and T. Mackey, Direct-to-consumer advertising with interactive internet ...
• Lindpaintner, K., The impact of pharmacogenetics and pharmacogenomics on drug ...
• Shin, J., Clinical pharmacogenomics of warfarin and clopidogrel. Journal of ...
• Papanikolaw, J., Bioinformatics emerges as key technology for developing new ...
• Zemlo, T., Pharmacogenomic promise, pitfalls. Drug Discovery & Development. Highland ...
• Amstutz, U. and B. Carleton, Pharmacogenetic testing: time for clinical ...
• Liou, S.-Y., F. Stringer, and M. Hirayama, The impact of ...
• Moe, J.L., Commercialization Considerations for Individualized Diagnostic and Drug Therapies ...
• Prows, C.A. and D.R. Prows, Medication Selection by Genotype: How ...
• Rawlins, M.D., Cutting the cost of drug development? Nature reviews ...
• Lazarou, J., B.H. Pomeranz, and P.N. Corey, Incidence of adverse ...
• Becquemont, L., Pharmacogenomics of adverse drug reactions: practical applications and ...
• Nelson, M., et al., Genome-wide approaches to identify pharmacogenetic contributions ...
• Thorn, C.F., T.E. Klein, and R.B. Altman, Pharmacogenomics and bioinformatics: ...
• Crews, K.R., et al., Pharmacogenomics and individualized medicine: translating science ...
• Maher, P.D. and M. Haffner, Orphan Drug Designation and Pharmacogenomics. ...
• Rioux, P.P., Clinical trials in pharmacogenetics and pharmacogenomics: methods and ...
• Vanakker, O.M. and A. De Paepe, Pharmacogenomics in children: advantages ...
• Ginsburg, G.S. and H.F. Willard, Genomic and personalized medicine: foundations ...
• Haga, S.B. and W. Burke, Practical ethics: establishing a pathway ...
• Dibyajyoti, S., E.T. Bin, and P. Swati, Bioinformatics: The effects ...
• DiMasi, J.A., R.W. Hansen, and H.G. Grabowski, The price of ...
• Brown, D. and G. Superti-Furga, Rediscovering the sweet spot in ...
• Xia, X., Bioinformatics and Drug Discovery. Current topics in medicinal ...
• Iskar, M., et al., Drug discovery in the age of ...
• Whittaker, P.A., What is the relevance of bioinformatics to pharmacology? ...
• Ortega, S.S., L.C.L. Cara, and M.K. Salvador, In silico pharmacology ...
• Song, C.M., S.J. Lim, and J.C. Tong, Recent advances in ...
• Speck-Planche, A. and M. Cordeiro, Computer-aided drug design, synthesis and ...
• Macalino, S.J.Y., et al., Role of computer-aided drug design in ...
• Yamanishi, Y., et al., Drug-target interaction prediction from chemical, genomic ...
• Gilbert, J., P. Henske, and A. Singh, Rebuilding big pharma's ...
• Ratti, E. and D. Trist, Continuing evolution of the drug ...
• Adams, C.P. and V.V. Brantner, Spending on new drug development. ...
• Dickson, M. and J.P. Gagnon, Key factors in the rising ...
• Tsaioun, K., et al. ADDME–Avoiding Drug Development Mistakes Early: central ...
• Klein, D. and A. Tabarrok, The drug discovery, development and ...
• Tamimi, N.A. and P. Ellis, Drug development: from concept to ...
• Wierenga, D.E. and R.C. Eaton, Drug Development and Approval Process. ...
• Katara, P., Role of bioinformatics and pharmacogenomics in drug discovery ...
• Collier, R., Rapidly rising clinical trial costs worry researchers. ۲۰۰۹, ...
• Myers, S. and A. Baker, Drug discoveryan operating model for ...
• Simoens, S., Pricing and reimbursement of orphan drugs: the need ...
• Liang, B.A. and T. Mackey, Direct-to-consumer advertising with interactive internet ...
• Lindpaintner, K., The impact of pharmacogenetics and pharmacogenomics on drug ...
• Shin, J., Clinical pharmacogenomics of warfarin and clopidogrel. Journal of ...
• Papanikolaw, J., Bioinformatics emerges as key technology for developing new ...
• Zemlo, T., Pharmacogenomic promise, pitfalls. Drug Discovery & Development. Highland ...
• Amstutz, U. and B. Carleton, Pharmacogenetic testing: time for clinical ...
• Liou, S.-Y., F. Stringer, and M. Hirayama, The impact of ...
• Moe, J.L., Commercialization Considerations for Individualized Diagnostic and Drug Therapies ...
• Prows, C.A. and D.R. Prows, Medication Selection by Genotype: How ...
• Rawlins, M.D., Cutting the cost of drug development? Nature reviews ...
• Lazarou, J., B.H. Pomeranz, and P.N. Corey, Incidence of adverse ...
• Becquemont, L., Pharmacogenomics of adverse drug reactions: practical applications and ...
• Nelson, M., et al., Genome-wide approaches to identify pharmacogenetic contributions ...
• Thorn, C.F., T.E. Klein, and R.B. Altman, Pharmacogenomics and bioinformatics: ...
• Crews, K.R., et al., Pharmacogenomics and individualized medicine: translating science ...
• Maher, P.D. and M. Haffner, Orphan Drug Designation and Pharmacogenomics. ...
• Rioux, P.P., Clinical trials in pharmacogenetics and pharmacogenomics: methods and ...
• Vanakker, O.M. and A. De Paepe, Pharmacogenomics in children: advantages ...
• Ginsburg, G.S. and H.F. Willard, Genomic and personalized medicine: foundations ...
• Haga, S.B. and W. Burke, Practical ethics: establishing a pathway ...
نمایش کامل مراجع